Approval · Notice of Compliance 17819 · 2016
BLEOMYCIN FOR INJECTION: Notice of Compliance 17819
Issued February 26, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17819
- Date
- February 26, 2016
- Company
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Canadian reference product
- BLENOXANE (Bristol Laboratories Of Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BLEOMYCIN FOR INJECTION | 02265982 | Marketed |
Medicinal ingredients
- BLEOMYCIN SULFATE 15 UNIT per VIAL